For allergic rhinitis and nasal polyps

- Immediate restoration of nasal breathing, decrease in nasal discharges, decrease in the dosages and frequency of application of vasoconstrictive medication.

- The growth of the CP is accompanied by stable remission with complete elimination of swelling, medication and full restoration of nasal breathing.

- Prevention of surgery.

- Normalization of the emotional life of the students and significant improvement in the quality of life.

 

Allergic conjunctivitis

- Immediate reduction of symptoms (e.g., itching) and decrease in the amount of medication.

- The growth of the CP is accompanied by complete elimination of skin itching, decrease the area covered with rash, and decrease the duration of use of medication.

- Normalization of the emotional life of the students and significant improvement in the quality of life.

 

States of immunodeficiency (secondary)

- Immediate elimination of clinical symptoms of secondary immunodeficiency, such as frequent infective and inflammatory processes in the lungs, bronchi, nasal passages, urinary system, GI tract, eyes, skin, and soft tissues.

- Further CP growth prevents development of similar complications.

- Significant improvements in the quality of life.

- Transition of children and adults from the “frequently sick” category into the “practically healthy” one.